Immunovant, Inc. (IMVT)
25.33
-0.28
(-1.09%)
USD |
NASDAQ |
Dec 30, 16:00
25.33
0.00 (0.00%)
After-Hours: 18:18
Immunovant Market Cap: 4.440B for Dec. 30, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Revvity, Inc. | 11.05B |
| Viridian Therapeutics, Inc. | 2.961B |
| Perspective Therapeutics, Inc. | 204.43M |
| Electromed, Inc. | 241.79M |
| Xtant Medical Holdings, Inc. | 107.47M |
Market Cap Related Metrics
| PEG Ratio | -0.3233 |
| Price to Book Value | 8.543 |
| Price | 25.33 |
| Earnings Yield | -11.17% |
| PEGY Ratio | -0.3233 |